Related Experiment Video

Updated: Jul 15, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Clinical trials update from the World Congress of Cardiology 2006

Marco Metra1, Savina Nodari, Tania Bordonali

  • 1University of Brescia c/o Spedali Civili, Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, P.zza Spedali Civili 1, 25123 Brescia, Italy. metramarco@libero.it

Expert Opinion on Pharmacotherapy
|April 12, 2007
PubMed

Insights

The World Congress of Cardiology 2006 highlighted new heart failure treatments and interventions. Landmark meta-analyses on drug-eluting stents and atrial fibrillation trials were also presented.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Clinical Trials

Background:

  • The World Congress of Cardiology 2006 (WCC-2006) convened key research in cardiovascular medicine.
  • Focus areas included heart failure, coronary artery disease, and arrhythmias.

Framework:

  • Summaries of trials involving understudied heart failure populations (e.g., elderly).
  • Presentation of novel therapeutic strategies like immune modulation therapy.
  • Evaluation of new intervention strategies, including the Cardiac Insufficiency Bisoprol-III study.

Implementation:

  • Discussion of patient monitoring trials, such as the Home or Hospital Heart Failure study.
  • Presentation of landmark meta-analyses on late events in patients with drug-eluting stents.
  • Review of trials on percutaneous patent foramen ovale closure.

Implications:

  • The findings inform clinical practice regarding heart failure management and coronary artery disease treatment.
  • Debates surrounding drug-eluting stent outcomes highlight ongoing research needs.
  • Results offer insights into atrial fibrillation management in elderly patients.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...